In vitro susceptibility of Sporothrix spp. to complexes coordinated with Co(II) and cobalt chloride hexahydrate
DOI:
https://doi.org/10.1590/s2175-97902022e20152Keywords:
Sporothrix brasiliensis, S, schenckii stricto sensu, Itraconazole, Minimal inhibitory concentrationAbstract
Sporothrix spp. are the major dimorphic fungus associated with a type of subcutaneous mycosis, sporotrichosis. The limitation of antifungal availability and the past reports of in vitro resistance of Sporothrix spp. clinical isolates makes it important to search for new compounds with antifungal activities. In this study, we therefore evaluate the in vitro activities of complexes coordinated with Co(II) and cobalt chloride hexahydrate against clinical isolates of Sporothrix spp. Broth microdilution test was performed as per M38-A2 from CLSI (2008) in duplicate for 31 clinical isolates of Sporothrix spp. (27 S. brasiliensis e 04 S. schenckii stricto sensu). The antifungal activities of the complexes coordinated with Co(II) and cobalt chloride hexahydrate were detected at a concentration range of 32-128 µg/mL for all isolates. None of the compounds demonstrated any cytotoxicity (to macrophage cells) at the concentration of 200 µg/mL. The activity against Sporothrix spp. recorded in this study instigate the continuity of experimental studies with Co(II) to search for the mechanisms of antifungal action as well as to evaluate its interaction with the commercial antifungal drugs.
Downloads
References
Ahmed SA, Gogal RM, Walsh JE. A new rapid and simple non- radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods. 1994;170(2):211-224.
Almeida-Paes R, Frases S, Monteiro PCF, Gutierrez- Galhardo MC, Zancopé-Oliveira RM, Nosanchuk JD. Growth conditions influence melanization of Brazilian clinical Sporothrix schenckii isolates. Microbes Infect. 2009;11(5):554-562.
Almeida-Paes R, Oliveira LC, Oliveira MME, Gutierrez- Galhardo MC, Nosanchuk JD, Zancopé-Oliveira RM. Fenotypic Characteristics Associated with Virulence of Clinical Isolates from the Sporothrix Complex. BioMed Res Int. 2015;1-10.
Almeida-Paes R, Oliveira MME, Freitas DFS, Valle ACF, Zancopé-Oliveira RM, Gutierrez-Galhardo MC. Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis Is Associated with Atypical Clinical Presentations. PLoS Negl Trop Dis. 2014;8(9):e3094.
Arrillaga-Moncrieff I, Capilla J, Mayayo E, Marimon R, Marine M, Gené J, et al. Different virulence levels of the species of Sporothrix in murine model. Clin Microbiol Infect. 2009;15(7):651-655.
Barros MBL, Paes RA, Schubach AO. Sporothrix schenckii and Sporotrichosis. Clin Microbiol Rev. 2011;24(4):633-654.
Butts A, Krysan DJ. Antifungal drug discovery: Something old and something new. PLoS Pathog. 2012;8(9):e1002870.
Castillo K, Bello-Vieda N, Nunez-Dallos N, Pastrana H, Celis A, Restrepo S, Hurtado J, Avila A. Metal complex derivatives of azole: a study on their synthesis, characterization, and antibacterial and antifungal activities. J Braz Chem Soc. 2016;27(12):2334-2347.
Chohan ZH, Rauf A, Naseer MM, Somra MA, Supuran CT. Antibacterial, antifungal and cytotoxic properties of some sulfonamide - derived chromones. J Enzyme Inhib Med Chem. 2006;21(2):173-177.
Clinical and Laboratory Standards Institute CLSI. Reference method for broth dilution antifungal suscetibility testing of filamentous fungi; approved standard - second edition. CLSI document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute. 2008.
Gałczyńska K, Ciepluch K, Madej Ł, Kurdziel K, Maciejewska B, Drulis-Kawa Z, Węgierek-Ciuk A, Lankoff A, Arabski M. Selective cytotoxicity and antifungal properties of copper(II) and cobalt(II) complexes with imidazole-4-acetate anion or 1-allylimidazole. Sci Rep. 2019;9(1):9777.
Gilaberte Y, Aspiroz C, Alejandre MC, Ciriano EA, Fortuño B, Charlez L, et al. Cutaneous Sporotrichosis treated with Photodynamic Therapy: an in vitro and in vivo study. Photomed Laser Surg. 2014;32(1):54-57.
Gonçalves BL, Ramos DF, Halicki PCB, da Silva PEA, Vicenti JRM, Synthesis, modeling and biological activity of new zinc(II) hydroxamates against Streptococcus pneumoniae Chem Data Collect. 2019;(22):100240-100248.
Heffern MC, Yamamoto N, Holbrook RJ, Eckermann AL, Meade TJ. Cobalt derivatives as promising therapeutic agents. Curr Opinion Chem Biol. 2013;17(2):189-196.
Heidrich D, Senter L, Valente P, Stopiglia CDO, Vetoratto G, Scroferneker ML. Successful treatment of terbinafine in a case of sporotrichosis. An Bras Dermatol. 2011;86(4 Supl 1):S182-185.
Helsel ME, White EJ, Razvi SZA, Alies B, Franz KJ. Chemical and functional properties of metal chelators that mobilize copper to elicit fungal killing of Cryptococcus neoformans Metallomics. 2017;9(1):69-81.
Hoffman AE, Miles L, Greenfield TJ, Shoen C, de Stefano M, Cynamon M, et al. Clinical isolates of Candida albicans, Candida tropicalis and Candida krusei have different susceptibilities to Co(II) and Cu (II) complexes of 1,10-phenanthroline. BioMetals. 2015;28(2):415-423.
Joseyphus RS, Nair MS. Synthesis, Characterization and Biological Studies of Some Co(II), Ni(II) and Cu(II) Complexes Derived from Indole-3- Carboxaldehyde and Glycylglycine as Schiff Base Ligand. Arabian J Chem. 2010;3(4):195-204.
Kalaivani S, Priya NP, Arunachalam S. Schiff Bases: Facile synthesis, spectra biocidal studies. Int J Appl Biol Pharm. 2012;3:219-223.
Kaur G, Kumar S, Dilbaghi N, Bhanjana G, Guru SK, Bhushan S, et al. Hybrid surfactants decorated with copper ions: aggregation behavior, antimicrobial activity and anti- proliferative effect. Phys Chem. 2016;18(34):23961-23970.
Kharadi GJ. Antitubercular and fluorescence studies of copper(II) complexes with quinolone family member, ciprofloxacin. Spectrochim Acta. 2011;79:898-903.
Marimon R, Serena C, Gené J, Cano J, Guarro J. In vitro antifungal susceptibilities of five species of Sporothrix Antimicrob Agents Chemother. 2008;52(2):732-734.
Melnic S, Prodius D, Stoeckli-Evans H, Shova S, Turta C. Synthesis and anti-tuberculosis activity of new hetero(Mn, Co, Ni)trinuclear iron(III) furoates. Eur J Med Chem. 2010;45(4):1465-9.
Mesa-Arango AC, Reyes-Montes MR, Pérez-Mejía A, Navarro-Barranco H, Souza V, Zúñiga G, et al. Phenotyping and Genotyping os Sporothrix schenckii Isolates According to Geographic Origin and Clinical Form os Sporotrichosis. J Clin Microbiol. 2002;40(8):3004-3011.
Nagababu P, Latha JNL, Pallavi P, Harish S, Satyanarayana S. Studies on antimicrobial activity of cobalt(III) ethylene diamine complexes. Can J Microbiol. 2008;52(12):1247-1254.
Oliveira DC, Lopes PGM, Spader TB, Mahl CD, Tronco- Alves GR, Lara VM, et al. Antifungal susceptibilities of Sporothrix albicans, S. brasiliensis, and S. luriei of the S. schenckii complex identified in Brazil. J Clin Microbiol . 2011;49(8):3047-3049.
Raja MR, Waterman SR, Qiu J, Bleher R, Williamson PR, O’Halloran TV. A copper hyperaccumulation phenotype correlates with pathogenesis in Cryptococcus neoformans Metallomics . 2013;5(4):363-71.
Rizzotto M. M et al Complexes as Antimicrobial Agents: A Search for Antibacterial Agents, Dr. Varaprasad Bobbarala (Ed.). https://mts.intechopen.com/books/a-search-for-antibacterial-agents/metal-complexes-as-antimicrobial-agents/ (accessed 13 March 2018). 2012.
Robbins N, Wright GD, Cowen LE. Antifungal drugs: the current armamentarium and development of new agents. Microbiol Spectr. 2016;4(5):FUNK-0002-2016.
Rodrigues AM, de Hoog GS, de Camargo ZP. Sporothrix species causing outbreaks in animals and humans driven by animal-animal transmission. PLoS Pathog . 2016;12(7):e1005638.
Roemer T, Krysan DJ. Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches. Cold Spring Harb. Perspect Med. 2014;4(5):e019703.
Saha K, Padhye S, Anson C, Powell K. Hydrothermal synthesis, crystal structure, spectroscopy, electrochemistry and antimycobacterial evaluation of the copper (II) ciprofloxacin complex: [Cu(cf)2(BF4)2]·6H2O. Inorg Chem Commun. 2002;5(12):1022-1027.
Sanchotene KO, Brandolt TM, Klafke GB, Poester VR, Xavier MO. In vitro susceptibility of Sporothrix brasiliensis: comparison of yeast and mycelial phases. Med Mycol. 2017;55(8):869-876.
Scorzoni L, de Paula e Silva ACA, Marcos CM, Assato PA, de Melo WCMA, et al. Antifungal therapy: New advances in the understanding and treatment of mycosis. Front Microbiol. 2017;8:36.
Sekhon BS. Metalloantibiotics and antibiotic mimics - an overview. J Pharm Educ Res. 2010;1(1):1-20.
Shaabani B, shaghaghi, Z. Synthesis, characterization and electrochemical porperties of two new Calix[4] arene derivates bearing two ferrocene imine or ferrocene AmineUnitsattheUpper rim. Tetrahedron. 2010;(66):3259-3264.
Silva MBT, Costa MMM, Torres CCS, Galhardo MCG, Valle ACF, Magalhães MAFM, et al. Esporotricose urbana: Epidemia negligenciada no Rio de Janeiro, Brasil. Cad Saúde Pública. 2012;28(10):1867-1880.
Stopiglia CDO, Magagnin CM, Castrillón MR, Mendes SDC, Heidrich D, Valente P, et al. Antifungal susceptibilities and identification of species of the Sporothrix schenckii complex isolated in Brazil. Med Mycol . 2014;52(1):56-64.
Turecka K, Chylewska A, Kawiak A, Waleron KF. Antifungal Activity and Mechanism of Action of the Co(III) Coordination Complexes With Diamine Chelate Ligands Against Reference and Clinical Strains of Candida spp. Front Microbiol . 2018;18(9):1594.
Zelenák V, Vargová Z, Gyoryová K. Correlation of Infrared Spectra of Zinc(II) Carboxylates with their Structures. Spectrochim Acta A Mol Biomol Spectrosc. 2007;66(2):262-272.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
